MCHP / Microchip Technology Incorporated (BMV) - Forecast, Price Target, Estimates, Predictions

Microchip Technology Incorporated
MX ˙ BMV ˙ US5950171042
Projected Stock Price
MX$1,465.00

Estimated share price by August 22, 2026.

Projected Revenue

1,769  MM ↑64.48%

Estimated quarterly revenue by December 31, 2026.

Projected Earnings Per Share

1.09 ↑1,368.29%

Estimated quarterly earnings by March 31, 2028.

Price Target

The average one-year price target for Microchip Technology Incorporated is MX$1,465.00. The forecasts range from a low of MX$1,128.31 to a high of MX$1,759.49.

Update Frequency: Monthly

Record Date Projection Date High Low Median Average
2025-08-22 2026-08-22 1,759.49 1,128.31 1,519.30 1,465.00
Stock Upgrades/Downgrades

This card shows analyst upgrades/downgrades for Microchip Technology Incorporated. An analyst rating is a classification that gives investors a sense of analyst sentiment about the direction and performance of an equity - usually a stock - over a period of time, typically 12 months.

The standard analyst ratings are generally as follows:
  • Buy/Overweight/Outperform - Any of these ratings conveys an analyst’s belief that the stock is likely to outperform a market index (e.g. the S&P 500).
  • Hold/Equal-Weight/Market Perform - Any of these ratings conveys an analyst’s belief that the stock is likely to perform in line with a market index.
  • Sell/Underweight/Underperform - Any of these ratings suggest that an analyst believes the stock is likely to underperform a market index.

When an analyst upgrades a stock, they are signaling that the company’s fundamentals are being undervalued by investors. It could also mean they believe the market is underestimating the company’s potential. The opposite is true when a stock receives a downgrade.

The average rating of each individual analyst’s rating is the consensus rating for a stock. This gives investors a broader sense of the overall sentiment for that stock.

Why Are Analyst Ratings important?

In addition to being able to interpret financial data, stock analysts have connections within the companies they cover that give them access to information retail investors do not have.

Therefore, analyst ratings can help you find opportunities in the market. However, they are guidelines more than recommendations. This is why it’s important to look at analyst ratings over a period of time.

If analysts change their ratings frequently, you should pay close attention to the company’s fundamentals. For example, has there been a significant change to the company’s earnings growth and/or debt?

You should also pay attention to the number of analysts covering a stock over the course of a year. In general, the more analysts who cover the stock give the consensus rating more credibility, but each individual rating less overall weight.

How to Use Analyst Ratings ?

Analyst ratings are one data point for you to consider. Here are some strategies you can use to fine tune your research.

Look at more than one analyst and don’t hesitate to look at analysts that have differing views. This can help challenge any preconceived ideas you have about a stock and point out ways in which your thesis for owning or avoiding a stock may have changed.

Compare a stock’s rating with other stocks in its industry or sector. In some cases, a stock is simply superior to others in its sector. However, at other times, it could be overvalued based on investor sentiment instead of fundamentals.

How are the Fintel Analyst Ratings different?

Analyst ratings by Fintel are presented in close to real-time to stay ahead of generalized information flow. Combined with target price estimates and revenue estimates for the company you have greater accuracy despite market volatility.

Date Analyst Prior Latest
Recommendation
Action
2024-12-03 Keybanc Overweight Overweight Maintains
2024-12-03 Stifel Buy Buy Maintains
2024-12-03 Needham Buy Buy Reiterate
2024-11-06 Susquehanna Positive Positive Maintains
2024-11-06 Evercore ISI Group Outperform Outperform Reiterate
2024-11-06 TD Cowen Hold Hold Maintains
2024-11-06 Jefferies Buy Buy Maintains
2024-11-06 Citigroup Buy Buy Maintains
2024-11-06 Keybanc Overweight Overweight Maintains
2024-11-06 Rosenblatt Buy Buy Maintains
2024-11-06 Piper Sandler Overweight Overweight Maintains
2024-11-06 Needham Buy Buy Maintains
2024-08-05 Rosenblatt Buy Buy Maintains
2024-08-05 Needham Buy Buy Maintains
2025-07-22 Susquehanna Positive Positive Maintains
2025-04-17 Stifel Buy Buy Maintains
2024-07-17 Susquehanna Positive Positive Maintains
2024-07-11 Morgan Stanley Overweight Equal-Weight Downgrade
2024-05-28 Mizuho Neutral Buy Upgrade
2024-05-24 Mizuho Neutral Buy Upgrade
2024-05-07 UBS Buy Buy Maintains
2024-05-07 Keybanc Overweight Overweight Maintains
2024-05-07 TD Cowen Hold Hold Maintains
2024-05-07 B. Riley Securities Buy Buy Maintains
2024-05-07 Citigroup Buy Buy Maintains
2024-05-07 Piper Sandler Neutral Neutral Reiterate
2024-05-07 Goldman Sachs Neutral Neutral Maintains
2024-05-07 Truist Securities Buy Buy Maintains
2024-05-07 Susquehanna Positive Positive Maintains
2024-05-07 Needham Buy Buy Maintains
2024-05-07 Mizuho Neutral Neutral Maintains
2024-05-01 Stifel Buy Buy Maintains
2024-04-18 Stifel Buy Buy Maintains
2024-04-16 Evercore ISI Group Outperform Initiate
2024-04-08 Susquehanna Positive Positive Maintains
2024-03-14 Stifel Buy Buy Reiterate
2024-02-05 Goldman Sachs Neutral Neutral Maintains
2024-02-02 Goldman Sachs Neutral Neutral Maintains
2024-02-02 UBS Buy Buy Maintains
2024-02-02 Stifel Buy Buy Maintains
2024-02-02 Susquehanna Positive Positive Maintains
2024-02-02 Needham Buy Buy Maintains
2024-01-30 Rosenblatt Buy Buy Reiterate
2024-01-18 Wolfe Research Peer Perform Outperform Upgrade
2024-01-09 Truist Securities Buy Buy Maintains
2024-01-09 Stifel Buy Buy Maintains
2024-01-04 Piper Sandler Overweight Neutral Downgrade
2023-11-08 Citigroup Neutral Buy Upgrade
2023-11-03 Piper Sandler Overweight Overweight Maintains
2023-11-03 Susquehanna Positive Positive Maintains
2023-11-03 Morgan Stanley Overweight Overweight Maintains
2023-11-03 Keybanc Overweight Overweight Maintains
2023-11-03 Needham Buy Buy Maintains
2023-10-24 Susquehanna Positive Positive Maintains
2023-10-11 Morgan Stanley Overweight Overweight Maintains
2023-09-20 Rosenblatt Buy Buy Reiterate
2023-08-07 Needham Buy Buy Reiterate
2023-08-04 Wells Fargo Equal-Weight Equal-Weight Maintains
2023-08-04 Susquehanna Positive Positive Maintains
2023-08-04 Morgan Stanley Overweight Overweight Maintains
2023-08-04 Rosenblatt Buy Buy Maintains
2023-08-04 Mizuho Neutral Neutral Maintains
2023-08-03 Rosenblatt Buy Buy Reiterate
2023-07-25 Susquehanna Positive Positive Maintains
2023-07-20 Mizuho Neutral Neutral Maintains
2023-07-20 Stifel Equal-Weight Equal-Weight Maintains
2023-07-20 Wolfe Research Peer Perform Initiate
2023-07-18 Citigroup Neutral Neutral Maintains
2023-07-14 Truist Securities Buy Buy Maintains
2023-06-13 Susquehanna Positive Positive Reiterate
2023-05-05 Truist Securities Buy Maintains
2023-05-05 Wells Fargo Equal-Weight Maintains
2023-05-05 Stifel Equal-Weight Maintains
2023-05-05 Citigroup Neutral Maintains
2023-05-05 Keybanc Overweight Maintains
2023-04-25 Susquehanna Positive Maintains
2023-03-08 Needham Buy Reiterate
2023-03-02 Needham Buy Reiterate
2023-02-06 Goldman Sachs Neutral Maintains
2023-02-03 Susquehanna Positive Maintains
2023-02-03 Wells Fargo Equal-Weight Maintains
2023-02-03 B. Riley Securities Buy Maintains
2023-02-03 Truist Securities Buy Maintains
2023-02-03 Credit Suisse Neutral Maintains
2023-02-03 Morgan Stanley Overweight Maintains
2023-02-03 Citigroup Neutral Maintains
2023-02-03 Raymond James Strong Buy Maintains
2023-02-03 Mizuho Neutral Maintains
2023-02-03 Piper Sandler Overweight Maintains
2023-02-03 Needham Buy Maintains
2023-02-03 Keybanc Overweight Maintains
2023-01-27 Wells Fargo Equal-Weight Maintains
2023-01-18 Citigroup Neutral Maintains
2022-11-29 Stifel Buy Maintains
2022-11-16 Credit Suisse Neutral Initiate
2022-11-07 Goldman Sachs Neutral Maintains
2022-11-04 Mizuho Neutral Maintains
2022-11-04 Raymond James Strong Buy Maintains
2022-11-04 Morgan Stanley Overweight Maintains
2022-11-04 Piper Sandler Overweight Maintains
2022-10-11 Wells Fargo Equal-Weight Maintains
2022-10-11 Citigroup Neutral Maintains
2022-08-03 Mizuho Neutral Maintains
2022-08-03 B. Riley Securities Buy Maintains
2022-08-03 Morgan Stanley Overweight Maintains
2022-08-03 Wells Fargo Equal-Weight Maintains
2022-08-03 Cowen & Co. Outperform Maintains
2022-08-03 Needham Buy Maintains
2022-07-11 Wells Fargo Equal-Weight Maintains
2022-06-29 B of A Securities Buy Maintains
2022-06-28 Stifel Hold Buy Upgrade
2022-06-15 B. Riley Securities Buy Maintains
2022-06-10 Morgan Stanley Overweight Maintains
2022-05-10 BMO Capital Outperform Maintains
2022-05-10 B. Riley Securities Buy Maintains
2022-05-10 Needham Buy Maintains
2022-05-10 Keybanc Overweight Maintains
2022-05-10 Mizuho Neutral Maintains
2022-05-10 Wells Fargo Equal-Weight Maintains
2022-05-10 Citigroup Neutral Maintains
2022-05-09 Morgan Stanley Overweight Maintains
2022-04-08 Truist Securities Buy Maintains
2022-03-28 Goldman Sachs Buy Neutral Downgrade
2022-03-09 UBS Buy Maintains
2022-02-04 Rosenblatt Buy Maintains
2022-01-31 UBS Neutral Buy Upgrade
2021-12-01 Jefferies Buy Maintains
2021-11-05 Raymond James Strong Buy Maintains
2021-11-05 Morgan Stanley Overweight Maintains
2021-11-05 Mizuho Neutral Maintains
2021-11-05 Credit Suisse Outperform Maintains
2021-11-05 Keybanc Overweight Maintains
2021-10-14 Stifel Hold Initiate
2021-10-13 Morgan Stanley Overweight Maintains
2021-10-13 UBS Neutral Initiate
2021-10-12 Wells Fargo Equal-Weight Maintains
2021-09-28 Wells Fargo Overweight Equal-Weight Downgrade
2021-09-17 B of A Securities Buy Maintains
2021-08-04 Susquehanna Positive Maintains
2021-08-04 Morgan Stanley Overweight Maintains
2021-08-04 Rosenblatt Buy Maintains
2021-08-04 Keybanc Overweight Maintains
2021-08-04 Needham Buy Maintains
2021-07-15 Mizuho Buy Neutral Downgrade
2021-07-06 Keybanc Overweight Maintains
2021-05-07 Rosenblatt Buy Maintains
2021-05-07 Morgan Stanley Overweight Maintains
2021-03-23 Longbow Research Neutral Buy Upgrade
2021-02-05 JP Morgan Overweight Maintains
2021-02-05 B. Riley FBR Buy Maintains
2021-02-05 Jefferies Buy Maintains
2021-02-05 Mizuho Buy Maintains
2021-02-05 Rosenblatt Buy Maintains
2021-02-05 Credit Suisse Outperform Maintains
2021-02-05 Morgan Stanley Overweight Maintains
2021-02-05 KeyBanc Overweight Maintains
2021-02-03 Vertical Research Buy Neutral Downgrade
2021-01-19 Raymond James Strong Buy Maintains
2021-01-13 Needham Buy Maintains
2021-01-06 KeyBanc Overweight Maintains
2020-12-14 Morgan Stanley Overweight Maintains
2020-11-06 Raymond James Strong Buy Maintains
2020-11-06 Morgan Stanley Overweight Maintains
2020-11-06 Rosenblatt Buy Reiterate
2020-11-06 Citigroup Buy Neutral Downgrade
2020-11-06 BMO Capital Outperform Maintains
2020-11-06 KeyBanc Overweight Maintains
2020-10-19 Morgan Stanley Equal-Weight Overweight Upgrade
2020-08-05 Needham Buy Maintains
2020-07-27 Needham Buy Maintains
2020-07-13 Raymond James Strong Buy Maintains
2020-07-07 KeyBanc Overweight Maintains
2020-06-16 Morgan Stanley Equal-Weight Maintains
2020-06-03 Piper Sandler Overweight Maintains
2020-06-03 Suntrust Robinson Humphrey Buy Maintains
2020-06-03 Citigroup Buy Maintains
2020-06-03 KeyBanc Overweight Maintains
2020-06-03 Needham Buy Maintains
2020-06-03 Raymond James Strong Buy Maintains
2020-05-08 CFRA Hold Maintains
2020-05-08 Needham Buy Maintains
2020-05-08 B. Riley FBR Neutral Maintains
2020-04-13 SunTrust Robinson Humphrey Buy Maintains
2020-04-09 Wells Fargo Overweight Maintains
2020-04-09 Susquehanna Positive Maintains
2020-04-09 JP Morgan Overweight Maintains
2020-04-09 B. Riley FBR Neutral Maintains
2020-04-08 Needham Buy Maintains
2020-04-03 Needham Buy Maintains
2020-03-31 KeyBanc Overweight Maintains
2020-03-30 Citigroup Buy Maintains
2020-03-19 B. Riley FBR Buy Neutral Downgrade
2020-03-18 Morgan Stanley Equal-Weight Maintains
2020-03-03 Rosenblatt Buy Maintains
2020-03-03 Morgan Stanley Equal-Weight Maintains
2020-03-03 B. Riley FBR Buy Maintains
2020-03-03 JP Morgan Overweight Maintains
2020-02-05 Raymond James Strong Buy Reiterate
2020-02-05 Rosenblatt Buy Reiterate
2020-02-05 CFRA Hold Maintains
2020-02-05 Credit Suisse Outperform Maintains
2020-01-21 Morgan Stanley Equal-Weight Maintains
2020-01-10 B of A Securities Neutral Buy Upgrade
2020-01-07 SunTrust Robinson Humphrey Buy Maintains
2020-01-07 KeyBanc Overweight Maintains
2019-12-20 Wells Fargo Overweight Maintains
2019-12-18 Morgan Stanley Equal-Weight Maintains
2019-12-04 SunTrust Robinson Humphrey Buy Maintains
2019-11-06 B. Riley Buy Maintains
2019-11-06 Morgan Stanley Equal-Weight Maintains
2019-11-06 Citigroup Buy Maintains
2019-11-06 Wells Fargo Outperform Maintains
2019-10-30 Raymond James Market Perform Strong Buy Upgrade
2019-10-01 KeyBanc Sector Weight Overweight Upgrade
2019-07-29 Wells Fargo Outperform Maintains
2019-07-09 Longbow Research Neutral Initiate
2019-06-25 Wells Fargo Outperform Initiate
2019-05-09 BMO Capital Outperform Maintains
2019-05-09 Mizuho Buy Maintains
2019-05-09 B. Riley Buy Maintains
2019-05-06 B. Riley Buy Buy Maintains
2019-02-22 Cowen & Co. Market Perform Initiate
2019-01-24 Needham Strong Buy Buy Downgrade
2018-12-19 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-11-13 BMO Capital Outperform Initiate
2018-11-08 Jefferies Buy Buy Maintains
2018-11-08 B. Riley FBR Buy Buy Maintains
2018-10-10 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-10-03 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-09-25 Raymond James Outperform Market Perform Downgrade
2018-09-25 KeyBanc Sector Weight Initiate
2018-09-17 Bank of America Buy Neutral Downgrade
2018-08-10 Nomura Buy Buy Maintains
2018-08-10 JP Morgan Overweight Overweight Maintains
2018-08-10 KeyBanc Overweight Overweight Maintains
2018-07-27 PiperJaffray Overweight Overweight Maintains
2018-07-19 Nomura Buy Initiate
2018-06-05 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-06-01 B. Riley FBR Buy Buy Maintains
2018-05-30 SunTrust Robinson Humphrey Buy Buy Maintains
2018-05-09 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-03-08 Goldman Sachs Neutral Buy Upgrade
2018-03-05 Mizuho Neutral Buy Upgrade
2018-03-02 SunTrust Robinson Humphrey Hold Buy Upgrade
2018-02-07 Morgan Stanley Equal-Weight Equal-Weight Maintains
2018-02-07 Bank of America Buy Buy Maintains
2017-12-19 PiperJaffray Overweight Initiate
2017-12-13 Morgan Stanley Equal-Weight Maintains
2017-11-07 B. Riley FBR Buy Maintains
2017-11-07 B. Riley Buy Maintains
2017-11-07 Credit Suisse Outperform Maintains
2017-11-07 Jefferies Buy Maintains
2017-11-01 Morgan Stanley Overweight Equal-Weight Downgrade
2017-10-06 Argus Buy Initiate
2017-06-16 Raymond James Outperform Initiate
2017-04-04 Summit Redstone Partners Hold Buy Upgrade
2017-02-08 Needham Buy Strong Buy Upgrade
2016-12-21 Susquehanna Positive Initiate
2016-11-08 Bank of America Neutral Buy Upgrade
2016-11-04 Goldman Sachs Sell Neutral Upgrade
2016-09-30 Mizuho Neutral Initiate
2016-08-09 JP Morgan Overweight Maintains
2016-08-09 Jefferies Buy Maintains
2016-08-09 Citigroup Buy Maintains
2016-05-17 CLSA Buy Initiate
2016-04-05 Goldman Sachs Sell Maintains
2016-02-04 Jefferies Buy Maintains
2016-01-20 B. Riley FBR Buy Maintains
2016-01-20 SunTrust Robinson Humphrey Neutral Maintains
2016-01-20 B. Riley Buy Maintains
2016-01-19 Morgan Stanley Equal-Weight Overweight Upgrade
2016-01-15 Needham Hold Buy Upgrade
2015-11-09 Bank of America Neutral Initiate
2015-11-05 B. Riley FBR Neutral Buy Upgrade
2015-09-08 JP Morgan Neutral Overweight Upgrade
2015-08-05 Jefferies Buy Maintains
2015-08-04 B. Riley FBR Neutral Maintains
2015-08-04 Stifel Nicolaus Buy Maintains
2015-08-04 B. Riley Neutral Maintains
2015-05-08 JP Morgan Neutral Maintains
2015-02-12 Stifel Nicolaus Buy Maintains
2015-01-30 Jefferies Buy Maintains
2014-12-18 Citigroup Buy Maintains
2014-10-31 Credit Suisse Outperform Maintains
2014-10-10 Credit Suisse Outperform Maintains
2014-10-10 Drexel Hamilton Buy Hold Downgrade
2014-10-10 Needham Buy Hold Downgrade
2014-08-01 B. Riley FBR Neutral Maintains
2014-08-01 B. Riley Neutral Maintains
2014-06-02 Goldman Sachs Buy Neutral Downgrade
2014-05-07 Stifel Nicolaus Buy Maintains
2014-05-07 JP Morgan Neutral Maintains
2014-04-22 Citigroup Buy Maintains
2014-04-04 Stifel Nicolaus Buy Maintains
2014-01-31 Citigroup Buy Maintains
2014-01-31 Stifel Nicolaus Buy Maintains
2013-12-10 Drexel Hamilton Buy Initiate
2013-11-18 Stephens & Co. Overweight Equal-Weight Downgrade
2013-10-31 Mizuho Neutral Buy Upgrade
2013-09-24 Goldman Sachs Neutral Buy Upgrade
2013-08-16 Morgan Stanley Equal-Weight Initiate
2013-08-01 Jefferies Buy Maintains
2013-08-01 Stifel Nicolaus Buy Maintains
2013-08-01 Susquehanna Positive Maintains
2013-06-04 Goldman Sachs Neutral Maintains
2013-06-04 JP Morgan Neutral Maintains
2013-06-04 Stifel Nicolaus Buy Maintains
2013-06-04 Citigroup Buy Maintains
2013-05-29 Citigroup Neutral Buy Upgrade
2013-05-03 Jefferies Buy Maintains
2013-03-04 ISI Group Buy Strong Buy Upgrade
2013-02-08 UBS Buy Maintains
2013-02-08 Jefferies Buy Maintains
2012-12-13 Goldman Sachs Sell Neutral Upgrade
2012-12-07 Needham Buy Initiate
2012-11-09 Stifel Nicolaus Buy Maintains
2012-10-16 UBS Buy Maintains
2012-10-16 Miller Tabak Neutral Maintains
2012-10-16 Jefferies Buy Maintains
2012-10-08 ISI Group Hold Maintains
2012-08-03 Barclays Equal-Weight Maintains
2012-08-03 Stifel Nicolaus Buy Maintains
2025-07-08 Keybanc Overweight Overweight Maintains
2025-07-08 Mizuho Outperform Outperform Maintains
2025-07-07 UBS Buy Buy Maintains
2025-07-07 Citigroup Buy Buy Maintains
2025-01-14 Keybanc Overweight Overweight Maintains
2025-02-07 Piper Sandler Overweight Overweight Reiterate
2025-02-07 Keybanc Overweight Overweight Maintains
2025-02-07 Raymond James Strong Buy Strong Buy Reiterate
2025-02-07 B. Riley Securities Buy Buy Reiterate
2025-02-07 Rosenblatt Buy Buy Maintains
2025-02-07 Needham Buy Buy Maintains
2025-02-06 Rosenblatt Buy Buy Maintains
2025-04-29 UBS Buy Buy Maintains
2025-02-04 Morgan Stanley Equal-Weight Equal-Weight Maintains
2024-07-31 Rosenblatt Buy Buy Maintains
2024-08-02 B. Riley Securities Buy Buy Maintains
2024-08-02 Citigroup Buy Buy Maintains
2024-08-02 Truist Securities Buy Buy Maintains
2024-08-02 Susquehanna Positive Positive Maintains
2024-08-02 JP Morgan Overweight Overweight Maintains
2024-08-02 B of A Securities Buy Neutral Downgrade
2024-10-21 Susquehanna Positive Positive Maintains
2025-04-11 Citigroup Buy Buy Maintains
2024-09-23 Truist Securities Buy Hold Downgrade
2024-08-16 Piper Sandler Neutral Overweight Upgrade
2025-01-10 Goldman Sachs Neutral Neutral Maintains
2025-01-10 Mizuho Outperform Outperform Maintains
2025-05-30 UBS Buy Buy Maintains
2025-05-30 Rosenblatt Buy Buy Maintains
2025-07-18 Stifel Buy Buy Maintains
2024-12-16 B of A Securities Neutral Underperform Downgrade
2025-03-04 Evercore ISI Group Outperform Outperform Maintains
2025-03-04 Mizuho Outperform Outperform Maintains
2025-03-04 Rosenblatt Buy Buy Maintains
2025-03-04 Needham Buy Buy Maintains
2025-04-21 Truist Securities Hold Hold Maintains
2025-08-08 Raymond James Strong Buy Strong Buy Maintains
2025-08-08 Piper Sandler Overweight Overweight Maintains
2025-08-08 Needham Buy Buy Maintains
2025-07-10 Goldman Sachs Buy Initiate
2025-06-12 Evercore ISI Group Outperform Outperform Maintains
2025-06-12 Mizuho Outperform Outperform Maintains
2025-05-09 UBS Buy Buy Maintains
2025-05-09 Citigroup Buy Buy Maintains
2025-05-09 Morgan Stanley Equal-Weight Equal-Weight Maintains
2025-05-09 Raymond James Strong Buy Strong Buy Reiterate
2025-05-09 Needham Buy Buy Reiterate
2025-06-09 Citigroup Buy Buy Maintains
2025-06-18 Truist Securities Hold Hold Maintains
2025-06-18 Cantor Fitzgerald Neutral Initiate
Revenue Estimates

The forecasted annual revenue of Microchip Technology Incorporated in 2029-03-31 is 9,266MM. )

Understanding a company’s revenue history gives investors a snapshot of its potential growth. Revenue growth is a solid predictor of earnings (or profit) growth. A company that can increase its revenue while keeping its operating costs constant has more available capital to reinvest into its business or return to shareholders through dividends or share buybacks.

However, investors should be careful before investing in a company that is growing revenue but showing declining earnings or is unprofitable. In some cases, this is simply a case of a young company that is still in an early growth phase. But if this is a mature company, it can indicate that other fundamental problems exist.

How to Interpret Revenue Estimates?

Fintel gives you revenue projections for stocks that cover 10 years between 2020 and 2030. Although past performance does not guarantee future results, you can be more confident in your decision to buy or sell a stock when you see a company with revenue that has a track record of increasing its revenue.

Update Frequency: Quarterly

Date Revenue Average Quarterly (MM) Number of Analysts (Quarterly) Revenue Average Annually (MM) Number of Analysts (Annually)
2025-09-30 2,226 3 -- --
2025-12-31 2,240 3 -- --
2026-03-31 2,273 3 9,451 4
2026-06-30 1,670 3 -- --
2026-09-30 1,745 3 -- --
2026-12-31 1,769 3 -- --
2027-03-31 -- -- 9,555 3
2028-03-31 -- -- 10,371 3
2029-03-31 -- -- 9,266 3
Earnings Estimates

The forecasted annual earnings of Microchip Technology Incorporated in 2030-03-31 is 4.97 per share.

One part of an analyst’s rating is a profit (i.e., earnings) estimate for the current quarter and/or future quarters. The measurement given is earnings per share (EPS). EPS is a metric that indicates how much a company earned as represented by one share of its stock over a specific period (typically three months).

Earnings per Share Calculation

To understand the earnings per share calculation, you must understand net income. Net income is the amount of money a company has left over after deducting appropriate expenses and taxes from its revenues).

The formula for earnings per share is net income divided by the total number of outstanding shares (i.e., available for purchase). For example:

Company A has a net income of $100 million and forty million outstanding shares. The EPS calculation is as follows:

100,000,000/40,000,000 = $2.50 per share

How to use Earnings Per Share in Stock Analysis

Earnings per share is an essential metric for you to consider when deciding to buy a stock. After all, a company with high earnings per share is productive and generates revenue in excess of its operating costs.

However, it’s not the only metric you should use. Metrics like price-to-earnings and debt-to-equity add additional perspective about a company’s health.

You should also be sure to compare a company’s EPS with a company in its sector. However, when you do, be aware that EPS is different and more important than net profit by itself. You may see a company that has a rising net profit. But if its outstanding shares are also rising, then its EPS might be flat or even edging lower.

Update Frequency: Quarterly

Date EPS Average (Quarterly) Number of Analysts (Quarterly) EPS Average (Annual) Number of Analysts (Annually)
2025-09-30 1.60 3 -- --
2025-12-31 1.62 3 -- --
2026-03-31 1.65 3 6.28 3
2026-06-30 0.96 3 -- --
2026-09-30 1.06 3 -- --
2026-12-31 1.11 3 -- --
2027-03-31 1.18 8 6.92 3
2027-06-30 0.94 4 -- --
2027-09-30 1.04 4 -- --
2027-12-31 1.05 4 -- --
2028-03-31 1.09 4 7.65 3
2029-03-31 -- -- 6.81 3
2030-03-31 -- -- 4.97 3
EBITDA Estimates

The forecasted annual EBITDA of Microchip Technology Incorporated in 2029-03-31 is 4,583MM.

EBIDTA is an acronym that stands for earnings before interest, taxes, depreciation, and amortization. Analysts and investors pay attention to EBITDA because it strips out items that a company must report on its balance sheet but doesn’t significantly impact its business. Here’s an explanation of what that means for each part of the acronym:

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

EBITDA vs. Net Income

Net income is the profit a company has left over after covering its operating expenses. However, net income includes the items that EBITDA excludes. That’s why most analysts prefer EBITDA because it better reflects the health of a company’s core business.

Update Frequency: Quarterly

Date EBITDA Average (MM Quarterly) Number of Analysts (Quarterly) EBITDA Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2027-03-31
2028-03-31
2029-03-31
EBIT Estimates

The forecasted annual EBIT of Microchip Technology Incorporated in 2027-03-31 is 3,299MM.

EBIT is an acronym that stands for earnings before interest and taxes. Analysts use EBIT to measure a company’s performance because it strips out tax expenses and the costs of the capital structure influencing profit. These don’t significantly impact a company’s business.

Interest: Loan interest and earnings are subject to change based on a company’s financial strategy and, in any event, are not part of its core activities.

Taxes: Taxes are affected by governmental policy that can distort a company’s perceived profitability.

NOTE: EBIT is sometimes synonymous with operating income. However, in some cases, operating income doesn’t include gains or losses from non-core activities.

EBIT vs. EBITDA

EBITDA also strips out depreciation and amortization from a company’s earnings:

Depreciation: This accounts for the expected depreciation on tangible assets and immaterial goods from company investments. But since these investments may ultimately increase a company’s efficiency and profit potential, they aren’t a good indicator of a company’s current profitability.

Amortization: This shows the gradual writing off of the initial cost of an asset. It differs from depreciation because it is typically used with intangible assets such as intellectual property (e.g., patents, copyrights, etc.)

Update Frequency: Quarterly

Date EBIT Average (MM Quarterly) Number of Analysts (Quarterly) EBIT Average (MM Annually) Number of Analysts (Annually)
2025-09-30
2025-12-31
2026-03-31
2027-03-31
Other Listings
CH:MCP
IT:1MCHP €56.69
US:MCHP $65.92
GB:0K19 $66.80
AT:MCHP
DE:MCP €55.85
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista